PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)- RESULTS FROM A MEDICAL CHART REVIEW STUDY
Abstract
Authors
WK Oh DF McDermott MS Duh L Antrs K Chen SP Sarda A Luka S Whittemore P Ramamurthy MP Neary TK Choueiri